Europe Gene Therapy Market Report 2017

January 2017 | 108 pages | ID: E31298DBB66EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Gene Therapy

Revenue, means the sales value of Gene Therapy

This report studies sales (consumption) of Gene Therapy in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Bluebird Bio
• Sangamo
• Spark Therapeutics
• Dimension Therapeutics
• Avalanche Bio
• Celladon
• Vical Inc.
• Advantagene

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Gene Therapy in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• In Vivo
• Ex Viv

Split by application, this report focuses on sales, market share and growth rate of Gene Therapy in each application, can be divided into

• Mechanobiology Universities
• Research Institutions
• Other

Contents

Europe Gene Therapy Market Report 2017

1 GENE THERAPY OVERVIEW

1.1 Product Overview and Scope of Gene Therapy
1.2 Classification of Gene Therapy
  1.2.1 In Vivo
  1.2.2 Ex Viv
1.3 Application of Gene Therapy
  1.3.1 Mechanobiology Universities
  1.3.2 Research Institutions
  1.3.3 Other
1.4 Gene Therapy Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Gene Therapy (2011-2021)
  1.5.1 Europe Gene Therapy Sales and Growth Rate (2011-2021)
  1.5.2 Europe Gene Therapy Revenue and Growth Rate (2011-2021)

2 EUROPE GENE THERAPY BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Gene Therapy Market Competition by Manufacturers
  2.1.1 Europe Gene Therapy Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Gene Therapy Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Gene Therapy (Volume and Value) by Type
  2.2.1 Europe Gene Therapy Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Gene Therapy Revenue and Market Share by Type (2011-2016)
2.3 Europe Gene Therapy (Volume and Value) by Countries
  2.3.1 Europe Gene Therapy Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Gene Therapy Revenue and Market Share by Countries (2011-2016)
2.4 Europe Gene Therapy (Volume) by Application

3 GERMANY GENE THERAPY (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Gene Therapy Sales and Value (2011-2016)
  3.1.1 Germany Gene Therapy Sales and Growth Rate (2011-2016)
  3.1.2 Germany Gene Therapy Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Gene Therapy Sales Price Trend (2011-2016)
3.2 Germany Gene Therapy Sales and Market Share by Manufacturers
3.3 Germany Gene Therapy Sales and Market Share by Type
3.4 Germany Gene Therapy Sales and Market Share by Application

4 FRANCE GENE THERAPY (VOLUME, VALUE AND SALES PRICE)

4.1 France Gene Therapy Sales and Value (2011-2016)
  4.1.1 France Gene Therapy Sales and Growth Rate (2011-2016)
  4.1.2 France Gene Therapy Revenue and Growth Rate (2011-2016)
  4.1.4 France Gene Therapy Sales Price Trend (2011-2016)
4.2 France Gene Therapy Sales and Market Share by Manufacturers
4.3 France Gene Therapy Sales and Market Share by Type
4.4 France Gene Therapy Sales and Market Share by Application

5 UK GENE THERAPY (VOLUME, VALUE AND SALES PRICE)

5.1 UK Gene Therapy Sales and Value (2011-2016)
  5.1.1 UK Gene Therapy Sales and Growth Rate (2011-2016)
  5.1.2 UK Gene Therapy Revenue and Growth Rate (2011-2016)
  5.1.5 UK Gene Therapy Sales Price Trend (2011-2016)
5.2 UK Gene Therapy Sales and Market Share by Manufacturers
5.3 UK Gene Therapy Sales and Market Share by Type
5.4 UK Gene Therapy Sales and Market Share by Application

6 RUSSIA GENE THERAPY (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Gene Therapy Sales and Value (2011-2016)
  6.1.1 Russia Gene Therapy Sales and Growth Rate (2011-2016)
  6.1.2 Russia Gene Therapy Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Gene Therapy Sales Price Trend (2011-2016)
6.2 Russia Gene Therapy Sales and Market Share by Manufacturers
6.3 Russia Gene Therapy Sales and Market Share by Type
6.4 Russia Gene Therapy Sales and Market Share by Application

7 ITALY GENE THERAPY (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Gene Therapy Sales and Value (2011-2016)
  7.1.1 Italy Gene Therapy Sales and Growth Rate (2011-2016)
  7.1.2 Italy Gene Therapy Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Gene Therapy Sales Price Trend (2011-2016)
7.2 Italy Gene Therapy Sales and Market Share by Manufacturers
7.3 Italy Gene Therapy Sales and Market Share by Type
7.4 Italy Gene Therapy Sales and Market Share by Application

8 SPAIN GENE THERAPY (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Gene Therapy Sales and Value (2011-2016)
  8.1.1 Spain Gene Therapy Sales and Growth Rate (2011-2016)
  8.1.2 Spain Gene Therapy Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Gene Therapy Sales Price Trend (2011-2016)
8.2 Spain Gene Therapy Sales and Market Share by Manufacturers
8.3 Spain Gene Therapy Sales and Market Share by Type
8.4 Spain Gene Therapy Sales and Market Share by Application

9 BENELUX GENE THERAPY (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Gene Therapy Sales and Value (2011-2016)
  9.1.1 Benelux Gene Therapy Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Gene Therapy Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Gene Therapy Sales Price Trend (2011-2016)
9.2 Benelux Gene Therapy Sales and Market Share by Manufacturers
9.3 Benelux Gene Therapy Sales and Market Share by Type
9.4 Benelux Gene Therapy Sales and Market Share by Application

10 EUROPE GENE THERAPY MANUFACTURERS ANALYSIS

10.1 Bluebird Bio
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Gene Therapy Product Type, Application and Specification
    10.1.2.1 In Vivo
    10.1.2.2 Ex Viv
  10.1.3 Bluebird Bio Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Sangamo
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Gene Therapy Product Type, Application and Specification
    10.2.2.1 In Vivo
    10.2.2.2 Ex Viv
  10.2.3 Sangamo Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Spark Therapeutics
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Gene Therapy Product Type, Application and Specification
    10.3.2.1 In Vivo
    10.3.2.2 Ex Viv
  10.3.3 Spark Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Dimension Therapeutics
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Gene Therapy Product Type, Application and Specification
    10.4.2.1 In Vivo
    10.4.2.2 Ex Viv
  10.4.3 Dimension Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Avalanche Bio
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Gene Therapy Product Type, Application and Specification
    10.5.2.1 In Vivo
    10.5.2.2 Ex Viv
  10.5.3 Avalanche Bio Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Celladon
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Gene Therapy Product Type, Application and Specification
    10.6.2.1 In Vivo
    10.6.2.2 Ex Viv
  10.6.3 Celladon Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Vical Inc.
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Gene Therapy Product Type, Application and Specification
    10.7.2.1 In Vivo
    10.7.2.2 Ex Viv
  10.7.3 Vical Inc. Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Advantagene
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Gene Therapy Product Type, Application and Specification
    10.8.2.1 In Vivo
    10.8.2.2 Ex Viv
  10.8.3 Advantagene Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview

11 GENE THERAPY MANUFACTURING COST ANALYSIS

11.1 Gene Therapy Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Gene Therapy

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Gene Therapy Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Gene Therapy Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE GENE THERAPY MARKET FORECAST (2016-2021)

14.1 Germany Gene Therapy Sales Forecast (2016-2021)
14.2 France Gene Therapy Sales Forecast (2016-2021)
14.3 UK Gene Therapy Sales Forecast (2016-2021)
14.4 Russia Gene Therapy Sales Forecast (2016-2021)
14.5 Italy Gene Therapy Sales Forecast (2016-2021)
14.6 Spain Gene Therapy Sales Forecast (2016-2021)
14.7 Benelux Gene Therapy Sales Forecast (2016-2021)
14.8 Europe Gene Therapy Sales Forecast by Type (2016-2021)
14.9 Europe Gene Therapy Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Gene Therapy
Table Classification of Gene Therapy
Figure Europe Sales Market Share of Gene Therapy by Type in 2015
Figure In Vivo Picture
Figure Ex Viv Picture
Table Application of Gene Therapy
Figure Europe Sales Market Share of Gene Therapy by Application in 2015
Figure Mechanobiology Universities Examples
Figure Research Institutions Examples
Figure Other Examples
Figure Germany Gene Therapy Revenue and Growth Rate (2011-2021)
Figure France Gene Therapy Revenue and Growth Rate (2011-2021)
Figure UK Gene Therapy Revenue and Growth Rate (2011-2021)
Figure Russia Gene Therapy Revenue and Growth Rate (2011-2021)
Figure Italy Gene Therapy Revenue and Growth Rate (2011-2021)
Figure Spain Gene Therapy Revenue and Growth Rate (2011-2021)
Figure Benelux Gene Therapy Revenue and Growth Rate (2011-2021)
Figure Europe Gene Therapy Sales and Growth Rate (2011-2021)
Figure Europe Gene Therapy Revenue and Growth Rate (2011-2021)
Table Europe Gene Therapy Sales of Key Manufacturers (2015 and 2016)
Table Europe Gene Therapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Gene Therapy Sales Share by Manufacturers
Figure 2016 Gene Therapy Sales Share by Manufacturers
Table Europe Gene Therapy Revenue by Manufacturers (2015 and 2016)
Table Europe Gene Therapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Gene Therapy Revenue Share by Manufacturers
Table 2016 Europe Gene Therapy Revenue Share by Manufacturers
Table Europe Gene Therapy Sales and Market Share by Type (2011-2016)
Table Europe Gene Therapy Sales Share by Type (2011-2016)
Figure Sales Market Share of Gene Therapy by Type (2011-2016)
Figure Europe Gene Therapy Sales Growth Rate by Type (2011-2016)
Table Europe Gene Therapy Revenue and Market Share by Type (2011-2016)
Table Europe Gene Therapy Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Gene Therapy by Type (2011-2016)
Figure Europe Gene Therapy Revenue Growth Rate by Type (2011-2016)
Table Europe Gene Therapy Sales and Market Share by Countries (2011-2016)
Table Europe Gene Therapy Sales Share by Countries (2011-2016)
Figure Sales Market Share of Gene Therapy by Countries (2011-2016)
Table Europe Gene Therapy Revenue and Market Share by Countries (2011-2016)
Table Europe Gene Therapy Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Gene Therapy by Countries (2011-2016)
Table Europe Gene Therapy Sales and Market Share by Application (2011-2016)
Table Europe Gene Therapy Sales Share by Application (2011-2016)
Figure Sales Market Share of Gene Therapy by Application (2011-2016)
Figure Germany Gene Therapy Sales and Growth Rate (2011-2016)
Figure Germany Gene Therapy Revenue and Growth Rate (2011-2016)
Figure Germany Gene Therapy Sales Price Trend (2011-2016)
Table Germany Gene Therapy Sales by Manufacturers (2015 and 2016)
Table Germany Gene Therapy Market Share by Manufacturers (2015 and 2016)
Table Germany Gene Therapy Sales by Type (2015 and 2016)
Table Germany Gene Therapy Market Share by Type (2015 and 2016)
Table Germany Gene Therapy Sales by Application (2015 and 2016)
Table Germany Gene Therapy Market Share by Application (2015 and 2016)
Figure France Gene Therapy Sales and Growth Rate (2011-2016)
Figure France Gene Therapy Revenue and Growth Rate (2011-2016)
Figure France Gene Therapy Sales Price Trend (2011-2016)
Table France Gene Therapy Sales by Manufacturers (2015 and 2016)
Table France Gene Therapy Market Share by Manufacturers (2015 and 2016)
Table France Gene Therapy Sales by Type (2015 and 2016)
Table France Gene Therapy Market Share by Type (2015 and 2016)
Table France Gene Therapy Sales by Application (2015 and 2016)
Table France Gene Therapy Market Share by Application (2015 and 2016)
Figure UK Gene Therapy Sales and Growth Rate (2011-2016)
Figure UK Gene Therapy Revenue and Growth Rate (2011-2016)
Figure UK Gene Therapy Sales Price Trend (2011-2016)
Table UK Gene Therapy Sales by Manufacturers (2015 and 2016)
Table UK Gene Therapy Market Share by Manufacturers (2015 and 2016)
Table UK Gene Therapy Sales by Type (2015 and 2016)
Table UK Gene Therapy Market Share by Type (2015 and 2016)
Table UK Gene Therapy Sales by Application (2015 and 2016)
Table UK Gene Therapy Market Share by Application (2015 and 2016)
Figure Russia Gene Therapy Sales and Growth Rate (2011-2016)
Figure Russia Gene Therapy Revenue and Growth Rate (2011-2016)
Figure Russia Gene Therapy Sales Price Trend (2011-2016)
Table Russia Gene Therapy Sales by Manufacturers (2015 and 2016)
Table Russia Gene Therapy Market Share by Manufacturers (2015 and 2016)
Table Russia Gene Therapy Sales by Type (2015 and 2016)
Table Russia Gene Therapy Market Share by Type (2015 and 2016)
Table Russia Gene Therapy Sales by Application (2015 and 2016)
Table Russia Gene Therapy Market Share by Application (2015 and 2016)
Figure Italy Gene Therapy Sales and Growth Rate (2011-2016)
Figure Italy Gene Therapy Revenue and Growth Rate (2011-2016)
Figure Italy Gene Therapy Sales Price Trend (2011-2016)
Table Italy Gene Therapy Sales by Manufacturers (2015 and 2016)
Table Italy Gene Therapy Market Share by Manufacturers (2015 and 2016)
Table Italy Gene Therapy Sales by Type (2015 and 2016)
Table Italy Gene Therapy Market Share by Type (2015 and 2016)
Table Italy Gene Therapy Sales by Application (2015 and 2016)
Table Italy Gene Therapy Market Share by Application (2015 and 2016)
Figure Spain Gene Therapy Sales and Growth Rate (2011-2016)
Figure Spain Gene Therapy Revenue and Growth Rate (2011-2016)
Figure Spain Gene Therapy Sales Price Trend (2011-2016)
Table Spain Gene Therapy Sales by Manufacturers (2015 and 2016)
Table Spain Gene Therapy Market Share by Manufacturers (2015 and 2016)
Table Spain Gene Therapy Sales by Type (2015 and 2016)
Table Spain Gene Therapy Market Share by Type (2015 and 2016)
Table Spain Gene Therapy Sales by Application (2015 and 2016)
Table Spain Gene Therapy Market Share by Application (2015 and 2016)
Figure Benelux Gene Therapy Sales and Growth Rate (2011-2016)
Figure Benelux Gene Therapy Revenue and Growth Rate (2011-2016)
Figure Benelux Gene Therapy Sales Price Trend (2011-2016)
Table Benelux Gene Therapy Sales by Manufacturers (2015 and 2016)
Table Benelux Gene Therapy Market Share by Manufacturers (2015 and 2016)
Table Benelux Gene Therapy Sales by Type (2015 and 2016)
Table Benelux Gene Therapy Market Share by Type (2015 and 2016)
Table Benelux Gene Therapy Sales by Application (2015 and 2016)
Table Benelux Gene Therapy Market Share by Application (2015 and 2016)
Table Gene Therapy Basic Information List
Table Bluebird Bio Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bluebird Bio Gene Therapy Sales Market Share (2011-2016)
Table Sangamo Basic Information List
Table Sangamo Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sangamo Gene Therapy Sales Market Share (2011-2016)
Table Spark Therapeutics Basic Information List
Table Spark Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Spark Therapeutics Gene Therapy Sales Market Share (2011-2016)
Table Dimension Therapeutics Basic Information List
Table Dimension Therapeutics Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dimension Therapeutics Gene Therapy Sales Market Share (2011-2016)
Table Avalanche Bio Basic Information List
Table Avalanche Bio Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Avalanche Bio Gene Therapy Sales Market Share (2011-2016)
Table Celladon Basic Information List
Table Celladon Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celladon Gene Therapy Sales Market Share (2011-2016)
Table Vical Inc. Basic Information List
Table Vical Inc. Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vical Inc. Gene Therapy Sales Market Share (2011-2016)
Table Advantagene Basic Information List
Table Advantagene Gene Therapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advantagene Gene Therapy Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gene Therapy
Figure Manufacturing Process Analysis of Gene Therapy
Figure Gene Therapy Industrial Chain Analysis
Table Raw Materials Sources of Gene Therapy Major Manufacturers in 2015
Table Major Buyers of Gene Therapy
Table Distributors/Traders List
Figure Germany Gene Therapy Sales and Growth Rate Forecast (2016-2021)
Figure Germany Gene Therapy Revenue and Growth Rate Forecast (2016-2021)
Figure France Gene Therapy Sales and Growth Rate Forecast (2016-2021)
Figure France Gene Therapy Revenue and Growth Rate Forecast (2016-2021)
Figure UK Gene Therapy Sales and Growth Rate Forecast (2016-2021)
Figure UK Gene Therapy Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Gene Therapy Sales and Growth Rate Forecast (2016-2021)
Figure Russia Gene Therapy Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Gene Therapy Sales and Growth Rate Forecast (2016-2021)
Figure Italy Gene Therapy Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Gene Therapy Sales and Growth Rate Forecast (2016-2021)
Figure Spain Gene Therapy Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Gene Therapy Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Gene Therapy Revenue and Growth Rate Forecast (2016-2021)
Table Europe Gene Therapy Sales Forecast by Type (2016-2021)
Table Europe Gene Therapy Sales Forecast by Application (2016-2021)